Its preservative prevents bacterial growth, allowing multiple withdrawals from the same vial
Enhanced Sleep Quality: Research suggests that CJC without DAC, an analog of GHRH, may positively affect sleep patterns
Key Insights Fatigue is a common but usually temporary side effect during the initial weeks or dose changes in GLP-1 therapy, caused largely by rapid calorie deficit, dehydration, and metabolic adjustments. Maintaining steady energy requires prioritising nutrient-dense meals rich in protein and complex carbohydrates, staying well hydrated, and managing electrolyte balance, which helps mitigate tiredness and supports overall metabolism. Gentle physical activity and good sleep hygiene are critical lifestyle adjustments that improve circulation, mood, and energy levels without overtaxing the body during the drug adaptation period. Persistent, worsening, or debilitating fatigue should prompt medical evaluation to exclude other causes, reassess medication dosing, and ensure safe continuation of GLP-1 therapy under healthcare supervision. Frequently asked questions Why do GLP-1 medications cause fatigue
European Journal of Nutrition, 61 , 413-428
Cmaj (1985) 133:65963
Genes associated with retinoid-interferon-induced mortality-19 (GRIM-19) regulate STAT3 and STAT5 phosphorylation to increase Treg differentiation [68]
